Tender detail
Open-house pharmaceutical discount agreements for indacaterol and glycopyrronium bromide
Summary
AOK Bayern is offering non-exclusive discount agreements to interested pharmaceutical companies under an open-house model for medicines containing the active ingredients indacaterol and glycopyrronium bromide (ATC R03AL04). The agreements run from 1 December 2026 at the earliest until 30 November 2028, and companies may join until 3 October 2028.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.